Free Trial
Fall Lock-In Sale! MarketBeat All Access, $149 a Year for Life
Lock In $149
Claim MarketBeat All Access Sale Promotion

AMN Healthcare Services (AMN) Competitors

AMN Healthcare Services logo
$43.03 +1.41 (+3.40%)
Closing price 10/21/2026 03:59 PM Eastern
Extended Trading
$43.90 +0.87 (+2.03%)
As of 07:24 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AMN vs. EYE, MEDP, VEEV, WST, and RDNT

Should you buy AMN Healthcare Services stock or one of its competitors? AMN Healthcare Services's main competitors and comparable companies include National Vision (EYE), Medpace (MEDP), Veeva Systems (VEEV), West Pharmaceutical Services (WST), and RadNet (RDNT). Companies are selected based on similarities in market, industry, and size.

How does AMN Healthcare Services compare to National Vision?

National Vision (NASDAQ:EYE) and AMN Healthcare Services (NYSE:AMN) are related small-cap companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk and dividends.

National Vision has a beta of 0.98, meaning that its stock price is 2% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.4, meaning that its stock price is 60% less volatile than the broader market.

AMN Healthcare Services has a net margin of 3.06% compared to National Vision's net margin of 2.47%. AMN Healthcare Services' return on equity of 19.92% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
National Vision2.47% 6.78% 3.01%
AMN Healthcare Services 3.06%19.92%5.93%

In the previous week, AMN Healthcare Services had 5 more articles in the media than National Vision. MarketBeat recorded 5 mentions for AMN Healthcare Services and 0 mentions for National Vision. AMN Healthcare Services' average media sentiment score of 0.06 beat National Vision's score of 0.00 indicating that AMN Healthcare Services is being referred to more favorably in the news media.

Company Overall Sentiment
National Vision Neutral
AMN Healthcare Services Neutral

99.2% of AMN Healthcare Services shares are held by institutional investors. 2.4% of National Vision shares are held by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

National Vision has higher earnings, but lower revenue than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Vision$1.99B0.70$29.60M$0.6129.05
AMN Healthcare Services$2.73B0.61-$95.70M$2.6816.06

National Vision presently has a consensus price target of $29.82, suggesting a potential upside of 68.27%. AMN Healthcare Services has a consensus price target of $36.50, suggesting a potential downside of 15.18%. Given National Vision's stronger consensus rating and higher possible upside, research analysts clearly believe National Vision is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Vision
0 Sell rating(s)
4 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.64
AMN Healthcare Services
0 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

National Vision and AMN Healthcare Services tied by winning 8 of the 16 factors compared between the two stocks.

How does AMN Healthcare Services compare to Medpace?

Medpace (NASDAQ:MEDP) and AMN Healthcare Services (NYSE:AMN) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, media sentiment, risk, profitability, valuation and earnings.

Medpace presently has a consensus target price of $607.73, suggesting a potential downside of 8.26%. AMN Healthcare Services has a consensus target price of $36.50, suggesting a potential downside of 15.18%. Given Medpace's higher possible upside, equities research analysts clearly believe Medpace is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medpace
0 Sell rating(s)
10 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.23
AMN Healthcare Services
0 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

Medpace has a beta of 1.18, meaning that its stock price is 18% more volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.4, meaning that its stock price is 60% less volatile than the broader market.

78.0% of Medpace shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 20.5% of Medpace shares are owned by company insiders. Comparatively, 1.1% of AMN Healthcare Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Medpace had 6 more articles in the media than AMN Healthcare Services. MarketBeat recorded 11 mentions for Medpace and 5 mentions for AMN Healthcare Services. Medpace's average media sentiment score of 0.51 beat AMN Healthcare Services' score of 0.06 indicating that Medpace is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Medpace
1 Very Positive mention(s)
4 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
AMN Healthcare Services
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Medpace has a net margin of 17.67% compared to AMN Healthcare Services' net margin of 3.06%. Medpace's return on equity of 110.15% beat AMN Healthcare Services' return on equity.

Company Net Margins Return on Equity Return on Assets
Medpace17.67% 110.15% 24.84%
AMN Healthcare Services 3.06%19.92%5.93%

Medpace has higher earnings, but lower revenue than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medpace$2.53B7.31$451.12M$17.0638.83
AMN Healthcare Services$2.73B0.61-$95.70M$2.6816.06

Summary

Medpace beats AMN Healthcare Services on 12 of the 16 factors compared between the two stocks.

How does AMN Healthcare Services compare to Veeva Systems?

AMN Healthcare Services (NYSE:AMN) and Veeva Systems (NYSE:VEEV) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations, media sentiment and institutional ownership.

AMN Healthcare Services has a beta of 0.4, meaning that its share price is 60% less volatile than the broader market. Comparatively, Veeva Systems has a beta of 0.93, meaning that its share price is 7% less volatile than the broader market.

Veeva Systems has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Veeva Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AMN Healthcare Services$2.73B0.61-$95.70M$2.6816.06
Veeva Systems$3.20B16.23$908.91M$6.0852.66

99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 88.2% of Veeva Systems shares are held by institutional investors. 1.1% of AMN Healthcare Services shares are held by insiders. Comparatively, 10.6% of Veeva Systems shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Veeva Systems had 18 more articles in the media than AMN Healthcare Services. MarketBeat recorded 23 mentions for Veeva Systems and 5 mentions for AMN Healthcare Services. Veeva Systems' average media sentiment score of 0.75 beat AMN Healthcare Services' score of 0.06 indicating that Veeva Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AMN Healthcare Services
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Veeva Systems
10 Very Positive mention(s)
4 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

AMN Healthcare Services currently has a consensus target price of $36.50, suggesting a potential downside of 15.18%. Veeva Systems has a consensus target price of $287.79, suggesting a potential downside of 10.12%. Given Veeva Systems' stronger consensus rating and higher probable upside, analysts clearly believe Veeva Systems is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AMN Healthcare Services
0 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
Veeva Systems
1 Sell rating(s)
8 Hold rating(s)
19 Buy rating(s)
0 Strong Buy rating(s)
2.64

Veeva Systems has a net margin of 29.34% compared to AMN Healthcare Services' net margin of 3.06%. AMN Healthcare Services' return on equity of 19.92% beat Veeva Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
AMN Healthcare Services3.06% 19.92% 5.93%
Veeva Systems 29.34%14.25%11.71%

Summary

Veeva Systems beats AMN Healthcare Services on 14 of the 16 factors compared between the two stocks.

How does AMN Healthcare Services compare to West Pharmaceutical Services?

AMN Healthcare Services (NYSE:AMN) and West Pharmaceutical Services (NYSE:WST) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, media sentiment, dividends, risk, profitability and institutional ownership.

West Pharmaceutical Services has a net margin of 16.98% compared to AMN Healthcare Services' net margin of 3.06%. West Pharmaceutical Services' return on equity of 20.11% beat AMN Healthcare Services' return on equity.

Company Net Margins Return on Equity Return on Assets
AMN Healthcare Services3.06% 19.92% 5.93%
West Pharmaceutical Services 16.98%20.11%14.83%

West Pharmaceutical Services has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AMN Healthcare Services$2.73B0.61-$95.70M$2.6816.06
West Pharmaceutical Services$3.07B9.02$493.70M$7.8150.44

AMN Healthcare Services has a beta of 0.4, meaning that its share price is 60% less volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.13, meaning that its share price is 13% more volatile than the broader market.

AMN Healthcare Services presently has a consensus price target of $36.50, indicating a potential downside of 15.18%. West Pharmaceutical Services has a consensus price target of $391.17, indicating a potential downside of 0.70%. Given West Pharmaceutical Services' stronger consensus rating and higher possible upside, analysts clearly believe West Pharmaceutical Services is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AMN Healthcare Services
0 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
West Pharmaceutical Services
0 Sell rating(s)
2 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.86

In the previous week, West Pharmaceutical Services had 6 more articles in the media than AMN Healthcare Services. MarketBeat recorded 11 mentions for West Pharmaceutical Services and 5 mentions for AMN Healthcare Services. West Pharmaceutical Services' average media sentiment score of 0.42 beat AMN Healthcare Services' score of 0.06 indicating that West Pharmaceutical Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AMN Healthcare Services
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
West Pharmaceutical Services
3 Very Positive mention(s)
0 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by company insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

West Pharmaceutical Services beats AMN Healthcare Services on 14 of the 16 factors compared between the two stocks.

How does AMN Healthcare Services compare to RadNet?

AMN Healthcare Services (NYSE:AMN) and RadNet (NASDAQ:RDNT) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, media sentiment, profitability, institutional ownership, valuation and earnings.

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 77.9% of RadNet shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by company insiders. Comparatively, 5.1% of RadNet shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

RadNet has lower revenue, but higher earnings than AMN Healthcare Services. RadNet is trading at a lower price-to-earnings ratio than AMN Healthcare Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AMN Healthcare Services$2.73B0.61-$95.70M$2.6816.06
RadNet$2.27B2.37-$18.65M-$0.27N/A

AMN Healthcare Services has a net margin of 3.06% compared to RadNet's net margin of -0.93%. AMN Healthcare Services' return on equity of 19.92% beat RadNet's return on equity.

Company Net Margins Return on Equity Return on Assets
AMN Healthcare Services3.06% 19.92% 5.93%
RadNet -0.93%2.61%0.91%

AMN Healthcare Services currently has a consensus target price of $36.50, suggesting a potential downside of 15.18%. RadNet has a consensus target price of $90.00, suggesting a potential upside of 31.56%. Given RadNet's stronger consensus rating and higher possible upside, analysts clearly believe RadNet is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AMN Healthcare Services
0 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
RadNet
1 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
3 Strong Buy rating(s)
3.11

AMN Healthcare Services has a beta of 0.4, suggesting that its share price is 60% less volatile than the broader market. Comparatively, RadNet has a beta of 1.41, suggesting that its share price is 41% more volatile than the broader market.

In the previous week, AMN Healthcare Services had 2 more articles in the media than RadNet. MarketBeat recorded 5 mentions for AMN Healthcare Services and 3 mentions for RadNet. AMN Healthcare Services' average media sentiment score of 0.06 beat RadNet's score of 0.00 indicating that AMN Healthcare Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AMN Healthcare Services
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
RadNet
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

AMN Healthcare Services beats RadNet on 9 of the 17 factors compared between the two stocks.

Get AMN Healthcare Services News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AMN vs. The Competition

MetricAMN Healthcare ServicesHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$1.61B$10.74B$7.59B$23.32B
Dividend YieldN/A2.58%2.49%3.71%
P/E Ratio16.0629.84216.3425.18
Price / Sales0.495.62587.9613.03
Price / Cash5.02112.1076.4534.21
Price / Book2.575.1910.764.74
Net Income-$95.70M$320.54M$3.51B$1.07B
7 Day Performance7.41%-0.01%0.31%-0.14%
1 Month Performance24.19%-3.72%-8.00%-2.53%
1 Year Performance110.76%16.28%4.51%6.63%

AMN Healthcare Services Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AMN
AMN Healthcare Services
1.5186 of 5 stars
$43.03
+3.4%
$36.50
-15.2%
+110.0%$1.61B$3.43B16.062,664
EYE
National Vision
3.7215 of 5 stars
$17.52
+0.5%
$29.82
+70.2%
-29.9%$1.38B$1.99B24.2113,138
MEDP
Medpace
2.9597 of 5 stars
$619.66
+0.2%
$607.73
-1.9%
+21.4%$17.26B$2.53B36.326,200
VEEV
Veeva Systems
3.1999 of 5 stars
$317.32
+2.2%
$287.79
-9.3%
+10.4%$50.25B$3.20B50.147,928
WST
West Pharmaceutical Services
3.8602 of 5 stars
$383.78
-0.1%
$391.17
+1.9%
+40.7%$27.03B$3.07B49.1410,800

Related Companies and Tools


This page (NYSE:AMN) was last updated on 10/22/2026 by MarketBeat.com Staff.
From Our Partners